Long-Term Liabilities: The sum of all non-current liabilities.
Caribou Biosciences, Inc. (CRBU) had Long-Term Liabilities of $25.88M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.67M |
|
$-54.10M |
|
-- |
|
$2.67M |
|
$50.24M |
|
$-47.58M |
|
$-6.52M |
|
$-54.10M |
|
$-44.94M |
|
$-54.10M |
|
$-54.10M |
|
$-54.10M |
|
$-44.94M |
|
$-47.58M |
|
$-46.70M |
|
93.03M |
|
93.03M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$192.51M |
|
$8.18M |
|
$28.40M |
|
$220.90M |
|
$28.89M |
|
-- |
|
|
Long-Term Liabilities |
$25.88M |
$54.77M |
|
$166.13M |
|
$166.13M |
|
$166.13M |
|
92.12M |
|
| Cash Flow Statement Financials | |
$-64.98M |
|
$73.42M |
|
$0.47M |
|
$16.34M |
|
$25.25M |
|
$8.91M |
|
$7.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1783.95% |
|
-1783.95% |
|
-- |
|
-2028.42% |
|
-2028.42% |
|
$-66.44M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.32 |
|
68.40 |
|
-32.56% |
|
-32.56% |
|
-24.49% |
|
-32.56% |
|
$1.80 |
|
$-0.71 |
|
$-0.70 |
|